1 1
Hunan Institute of Occupational Diseases Prevention and Treatment, China
Background and Aims: To evaluate therapeutic efficacy and safety of the granloeyte-macrophage cology-stimulating factor(GM-CSF)inhalation in patients with recurrent pulmonary alveolar pmteinosis(PAP)
Methods: 3 cases were treated by GM-CSF inhalation. Compare the clinical data of the pulmonary function and SPO2, observe the clinical symptoms and pulmonary lesions.
Results:
The pulmonary function test and manifestations were improved obviously, and the ground-glass opacity was improved in highresolution CT. The average of SPO2 increased from 53 mmHg to 73 mmHg, FVC/pred increased from 55.4% to 74.9%, FEV1% increased from 60.9% to 76.4%, DLCO/Pred increased from 35.5% to 52.3% by received GM-CSF inhalation. There were no any adverse reactions in 3 cases.
Conclusion:
Inhaled GM-CSF therapy is effective and safe in recurrent PAP. But the long-term effect remains to be seen. Background and Aims: Although serum anti-GM-CSF autoantibody is presence in patients with autoimmune pulmonary alveolar proteinosis (aPAP), this autoantibody titter is not related to disease severity or prediction for the prognosis. Even if autoantibody level is extraordinary high, some cases show a spontaneous remission. Furthermore, when treated by whole lung lavage method on hemithorax, other lung which has not washed can be improved. With these facts, we hypothesize that some kind of fluid elements including cytokine/chemokine increase activity of alveolar macrophage in aPAP and may contribute improvement of disease condition.
Methods: Clinical course of each cases including therapy with whole lung lavage and/or GM-CSF inhalation were divided into the progression stage and the remission stage. Comprehensive serum cytokine/chemokine levels were measured at each point in time and analyzed by a multiplex immunoassay system.
Results: The compositions of cytokines were different between the progression stage and the remission stage. In particular of the remission stage, it showed the elevation of the inflammatory cytokine levels concerning the activation of M1 macrophages such as interferon gamma.
In cases of aPAP, there is a possibility of improving the disease activity in accordance of a high serum inflammatory cytokine levels which activate M1 alveolar macrophages. Methods: In this case report we present a female patient who were diagnosed as TSC at the age of 47.
Results: 47-year-old female patient presented with dyspnea, fatigue and seizure. Although she felt dyspnea for long time she stated that she was healthy until last month. Her creatinine level, liver function tests were high and she had mild hypoxemia. Abdominal ultrasonography revealed renal and hepatic angiomyolipomas (AML). Cranial MRI revealed agenesis of septum pellucidum and in thorax CT there were cysts consistent with lymphangioleiomyomatosis (LAM). She dagnosed as TSC. She denied family history of TSC.
While, seizure and other TSC-associated neuropsychiatric disorders mostly appear during childhood, renal AML and LAM which are the most important causes of morbidity, become significant during adulthood. However in this case, neurological manifestations also became prominent in adulthood. Thus in cases with neurological, pulmonary and renal findings, TSC should be kept in mind even they are in late adulthood. 
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